{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T14:14:36Z","timestamp":1769264076045,"version":"3.49.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,13]]},"DOI":"10.7759\/cureus.73573","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T09:48:55Z","timestamp":1731491335000},"source":"Crossref","is-referenced-by-count":1,"title":["Risky Remedy: Rasburicase-Induced Methemoglobinemia in Tumor Lysis Syndrome Complicated by G6PD Deficiency"],"prefix":"10.7759","author":[{"given":"Supriya","family":"Peshin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakshi","family":"Singal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagaishwarya","family":"Moka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0904569","article-title":"The tumor lysis syndrome","volume":"364","author":"Howard SC","year":"2011","unstructured":"Howard SC, Jones DP, Pui CH. The tumor lysis syndrome. N Engl J Med. 2011, 364:1844-54. 10.1056\/NEJMra0904569","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.0177","article-title":"Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review","volume":"26","author":"Coiffier B","year":"2008","unstructured":"Coiffier B, Altman A, Pui CH, Younes A, Cairo MS. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol. 2008, 26:2767-78. 10.1200\/JCO.2007.15.0177","journal-title":"J Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-240967","article-title":"Rasburicase-induced haemolysis and methemoglobinemia: an ongoing issue","volume":"14","author":"Madanat L","year":"2021","unstructured":"Madanat L, Schoenherr D, Wey E, Gupta R. Rasburicase-induced haemolysis and methemoglobinemia: an ongoing issue. BMJ Case Rep. 2021, 14:240967. 10.1136\/bcr-2020-240967","journal-title":"BMJ Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000944","article-title":"Glucose-6-phosphate dehydrogenase deficiency","volume":"136","author":"Luzzatto L","year":"2020","unstructured":"Luzzatto L, Ally M, Notaro R. Glucose-6-phosphate dehydrogenase deficiency. Blood. 2020, 136:1225-40. 10.1182\/blood.2019000944","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05094.x","article-title":"Tumour lysis syndrome: new therapeutic strategies and classification","volume":"127","author":"Cairo MS","year":"2004","unstructured":"Cairo MS, Bishop M. Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol. 2004, 127:3-11. 10.1111\/j.1365-2141.2004.05094.x","journal-title":"Br J Haematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25435","article-title":"Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myeloma","volume":"94","author":"Forsberg PA","year":"2019","unstructured":"Forsberg PA, Rossi AC, Boyer A, et al.. Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myeloma. Am J Hematol. 2019, 94:539-45. 10.1002\/ajh.25435","journal-title":"Am J Hematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60073-2","article-title":"Glucose-6-phosphate dehydrogenase deficiency","volume":"371","author":"Cappellini MD","year":"2008","unstructured":"Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008, 371:64-74. 10.1016\/S0140-6736(08)60073-2","journal-title":"Lancet"},{"key":"ref8","article-title":"Methemoglobinemia induced by rasburicase in a G6PD-deficient patient: a case report","volume":"93","author":"Lim YK","year":"2014","unstructured":"Lim YK, Otsuka Y, Shinoda H, et al.. Methemoglobinemia induced by rasburicase in a G6PD-deficient patient: a case report. Ann Hematol. 2014, 93:1797-9.","journal-title":"Ann Hematol"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2008.12.005","article-title":"The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis","volume":"42","author":"Nkhoma ET","year":"2009","unstructured":"Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis. 2009, 42:267-78.","journal-title":"Blood Cells Mol Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/314996-risky-remedy-rasburicase-induced-methemoglobinemia-in-tumor-lysis-syndrome-complicated-by-g6pd-deficiency","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T09:48:58Z","timestamp":1731491338000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/314996-risky-remedy-rasburicase-induced-methemoglobinemia-in-tumor-lysis-syndrome-complicated-by-g6pd-deficiency"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,13]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.73573","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,13]]}}}